Literature DB >> 17382138

Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms.

Joseph Abarbanel1, Esther-Lee Marcus.   

Abstract

OBJECTIVES: To determine the prevalence of impaired detrusor contractility (IDC) with and without detrusor hyperactivity (DH) among community-dwelling elderly with lower urinary tract symptoms and to identify which patients are at a greater risk of having a hypocontractile detrusor.
METHODS: We performed a retrospective chart review of all patients 70 years old or older with storage and/or voiding lower urinary tract symptoms who had undergone urodynamic pressure-flow studies in a urodynamic referral center during a 2-year period.
RESULTS: During the study period, 181 patients (82 men [45%] and 99 women [55%]), aged 70 years or older (mean age 75.7 +/- 4.8), underwent urodynamic studies. IDC was detected in 39 (48%) of the 82 men and in 12 (12%) of the 99 women. Two thirds of the men and one half of the women with IDC also had involuntary detrusor contractions during the filling phase and/or low bladder compliance. The prevalence of IDC/DH-IDC was significantly greater in those with a history of urinary retention and an indwelling urethral catheter.
CONCLUSIONS: Detrusor-impaired contractility is an important pathophysiologic mechanism in older patients with lower urinary tract symptoms, especially in men. Establishing the diagnosis by urodynamic pressure-flow studies is crucial for determining treatment--potentially harmful to this vulnerable population--from objective parameters rather than by empirical decisions.

Entities:  

Mesh:

Year:  2007        PMID: 17382138     DOI: 10.1016/j.urology.2006.11.019

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  48 in total

1.  Neurogenic Causes of Detrusor Underactivity.

Authors:  Brian T Kadow; Pradeep Tyagi; Christopher J Chermansky
Journal:  Curr Bladder Dysfunct Rep       Date:  2015-09-15

Review 2.  Underactive Bladder.

Authors:  Himanshu Aggarwal; Philippe E Zimmern
Journal:  Curr Urol Rep       Date:  2016-03       Impact factor: 3.092

3.  Urinary retention and catheter use among U.S. female Medicare beneficiaries: Prevalence and risk factors.

Authors:  Joshua A Cohn; Shenghua Ni; Melissa R Kaufman; Amy J Graves; David F Penson; Roger R Dmochowski; W Stuart Reynolds
Journal:  Neurourol Urodyn       Date:  2017-03-07       Impact factor: 2.696

4.  A new look at detrusor underactivity: impaired contractility versus afferent dysfunction.

Authors:  Anne M Suskind; Phillip P Smith
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

Review 5.  Underactive bladder: A review of the current treatment concepts.

Authors:  Ömer Bayrak; Roger Roman Dmochowski
Journal:  Turk J Urol       Date:  2019-02-04

Review 6.  Voiding dysfunction due to detrusor underactivity: an overview.

Authors:  Marcus J Drake; Jonathan Williams; Dominika A Bijos
Journal:  Nat Rev Urol       Date:  2014-07-08       Impact factor: 14.432

Review 7.  Defining and advancing education and conservative therapies of underactive bladder.

Authors:  Tomas L Griebling; Catherine E DuBeau; George Kuchel; Mary H Wilde; Michelle Lajiness; Hikaru Tomoe; Ananias Diokno; Andrew Vereecke; Michael B Chancellor
Journal:  Int Urol Nephrol       Date:  2014-09-20       Impact factor: 2.370

Review 8.  Pathophysiology and animal modeling of underactive bladder.

Authors:  Pradeep Tyagi; Phillip P Smith; George A Kuchel; William C de Groat; Lori A Birder; Christopher J Chermansky; Rosalyn M Adam; Vincent Tse; Michael B Chancellor; Naoki Yoshimura
Journal:  Int Urol Nephrol       Date:  2014-09-20       Impact factor: 2.370

9.  Etiology and management of urinary retention in women.

Authors:  Amit Mevcha; Marcus J Drake
Journal:  Indian J Urol       Date:  2010-04

10.  Ultrasound detrusor wall thickness measurement in combination with bladder capacity can safely detect detrusor underactivity in adult men.

Authors:  Kevin L J Rademakers; Gommert A van Koeveringe; Matthias Oelke
Journal:  World J Urol       Date:  2016-07-22       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.